PODCAST

NephSpace

NephSpace makes new kidney research easy and fun to follow. Every week, Dr. Wael Hussein, an academic nephrologist in Memphis, picks the most interesting new papers and news in nephrology, and two hosts talk them through: the story, the key numbers, why it matters, and an honest take on what the study does and doesn"t prove. Weekly episodes cover that week"s picks from the kidney journals, the big general journals and the specialty news. Deep Dives follow one question further: two treatments

health & fitness medicine

All Episodes

24:41

Weekly · Oct 5: Drugs for CKD and Dialysis, the Heart...

NephSpace ·

2026/10/05

A new lipid guideline makes reduced kidney function a reason for a statin; in 2024, before it arrived, most patients for whom kidney function is now the reason had no statin prescription. An editorial asks whether GLP-1 drugs belong in dialysis units before the trials are done. A review says dialysis adequacy should be measured by what it does for the heart, troponin turns out to be a moving target during a session, and an AI reads photos of fistulas. Five picks from the week of September

en-us

2:22

Trailer · Why NephSpace

NephSpace ·

2026/10/03

I want to keep up with nephrology. But the new papers sit behind logins and scattered across sites, so I end up doomscrolling instead. NephSpace brings the week's kidney research and news together, out loud: one weekly episode on what's new, plus deep dives in between, made for the couch, the run and the drive to work.Let's transform scroll time into learning time. Knowledge, transformed: easy to reach, hard to stop.Follow on Apple Podcasts:

en-us

20:11

Deep Dive · Two Roads: Hemodiafiltration or Medium...

NephSpace ·

2026/10/02

Two dialysis patients, same city, same week. One gets a new machine that filters and replaces more than 20 liters every session. The other gets the same old machine with a new filter. Both are told it's the future. Hemodiafiltration has a survival trial but needs new machines. Medium cutoff dialyzers drop into today's machines but have no survival evidence against standard dialysis. A detective story with a Fight Night verdict, including who makes, sells and funds each road.The takeaway:

en-us

30:56

Weekly · Oct 2: The Middle-Molecule Race, a Dipstick...

NephSpace ·

2026/10/02

Two ways to clear more middle molecules arrive in US dialysis units at once. A urine dipstick can show whether patients are taking their SGLT2 inhibitor. Two papers disagree about who should let AI write the notes. Nine picks from the week of September 21, 2026, each with the story, the numbers and a take.Disclosure: Dr. Hussein serves on the Fresenius Medical Care US Home Medical Advisory Board. Fresenius sells hemodiafiltration machines, which are discussed in this episode.Chapters00:00

en-us

4 results

NephSpace

All Episodes

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

Healthy Chat

DR ALI BANIHAMOUR

Dingue ‐ RTS

RTS - Radio Télévision Suisse

To Birth and Beyond

Anita Lambert & Jessie Mundell

The Fitness League

Alessandra and Josh Scutnik, Joelle...